Trial intelligence / Profile preview

MVA-BN smallpox vaccine study in children under 12 years

2012-005137-37Phase 2Completed

Sponsor
Bavarian Nordic
Start
May 2013
Modality
Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 2 trial of JYNNEOS in smallpox, sponsored by Bavarian Nordic. Started May 2013; status: completed.

02

Drugs

JYNNEOS
03

Conditions

smallpox

Beyond the preview

Go deeper on 2012-005137-37.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-005137-37.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call